Budesonide Dry Powder Inhaler: Began Phase III study

Canadian Medical Laboratories Ltd. (TSE:CLC), Mississauga, Ontario Product: Budesonide Dry Powder Inhaler Business: Autoimmune/Inflammation Therapeutic category: Steroid Target: Immune cells Descripti...